These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 15468375

  • 1. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis.
    Henrickson M, Reiff A.
    J Rheumatol; 2004 Oct; 31(10):2055-61. PubMed ID: 15468375
    [Abstract] [Full Text] [Related]

  • 2. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD, Sack KE, Davis JC.
    N Engl J Med; 2002 May 02; 346(18):1349-56. PubMed ID: 11986408
    [Abstract] [Full Text] [Related]

  • 3. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J.
    Arthritis Rheum; 2003 Jun 02; 48(6):1667-75. PubMed ID: 12794835
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
    Davis JC, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W, Enbrel Ankylosing Spondylitis Study Group.
    Arthritis Rheum; 2003 Nov 02; 48(11):3230-6. PubMed ID: 14613288
    [Abstract] [Full Text] [Related]

  • 5. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy.
    Tse SM, Burgos-Vargas R, Laxer RM.
    Arthritis Rheum; 2005 Jul 02; 52(7):2103-8. PubMed ID: 15986366
    [Abstract] [Full Text] [Related]

  • 6. Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
    Baraliakos X, Brandt J, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J.
    Arthritis Rheum; 2005 Dec 15; 53(6):856-63. PubMed ID: 16342093
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.
    Arthritis Rheum; 2003 Apr 15; 48(4):1093-101. PubMed ID: 12687553
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
    Horneff G, Ebert A, Fitter S, Minden K, Foeldvari I, Kümmerle-Deschner J, Thon A, Girschick HJ, Weller F, Huppertz HI.
    Rheumatology (Oxford); 2009 Aug 15; 48(8):916-9. PubMed ID: 19483091
    [Abstract] [Full Text] [Related]

  • 9. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
    Davis JC, van der Heijde DM, Braun J, Dougados M, Cush J, Clegg D, Inman RD, Kivitz A, Zhou L, Solinger A, Tsuji W.
    Ann Rheum Dis; 2005 Nov 15; 64(11):1557-62. PubMed ID: 15843448
    [Abstract] [Full Text] [Related]

  • 10. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
    Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2006 Jun 15; 54(6):1987-94. PubMed ID: 16732547
    [Abstract] [Full Text] [Related]

  • 11. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
    Liang TC, Yang YH, Lin YT, Chiang BL.
    J Microbiol Immunol Infect; 2005 Dec 15; 38(6):447-50. PubMed ID: 16341347
    [Abstract] [Full Text] [Related]

  • 12. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
    Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC.
    J Rheumatol; 2005 Oct 15; 32(10):1911-7. PubMed ID: 16206346
    [Abstract] [Full Text] [Related]

  • 13. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J, Listing J, Haibel H, Sörensen H, Schwebig A, Rudwaleit M, Sieper J, Braun J.
    Rheumatology (Oxford); 2005 Mar 15; 44(3):342-8. PubMed ID: 15561737
    [Abstract] [Full Text] [Related]

  • 14. Community-based evaluation of etanercept in patients with rheumatoid arthritis.
    Farahani P, Levine M, Gaebel K, Wang EC, Khalidi N.
    J Rheumatol; 2006 Apr 15; 33(4):665-70. PubMed ID: 16568506
    [Abstract] [Full Text] [Related]

  • 15. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.
    Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J.
    J Rheumatol; 2004 Mar 15; 31(3):531-8. PubMed ID: 14994401
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study of etanercept for treating ankylosing spondylitis].
    Liang LQ, Zhan ZP, Ye YJ, Fu D, Xu HS, Yang XY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug 15; 28(8):1349-51. PubMed ID: 18753057
    [Abstract] [Full Text] [Related]

  • 17. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H.
    J Clin Pharmacol; 2005 May 15; 45(5):490-7. PubMed ID: 15831771
    [Abstract] [Full Text] [Related]

  • 18. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH, Lee HJ, Sung IH, Kim TH.
    J Rheumatol; 2007 Aug 15; 34(8):1753-9. PubMed ID: 17610317
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.
    Takei S, Groh D, Bernstein B, Shaham B, Gallagher K, Reiff A.
    J Rheumatol; 2001 Jul 15; 28(7):1677-80. PubMed ID: 11469478
    [Abstract] [Full Text] [Related]

  • 20. Etanercept therapy in children with juvenile rheumatoid arthritis.
    Hung JJ, Huang JL.
    J Microbiol Immunol Infect; 2005 Dec 15; 38(6):444-6. PubMed ID: 16341346
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.